Angle Regulatory News (AGL)



Regulatory News for Angle (AGL)


Share Price: 58.75Bid: 57.50Ask: 60.00Change: 0.00 (0.00%)No Movement on Angle
Spread: 2.50Spread as %: 4.35%Open: 53.50High: 59.49Low: 52.70Yesterday’s Close: 58.75





Geomerics Milestone Payment

Wed, 16th May 2012 07:00

RNS Number : 4200D
Angle PLC
16 May 2012
 

?

 

 

For immediate release

16 May 2012

 

ANGLE plc

("ANGLE" or "the Company")

 

Geomerics Receives Final Milestone Payment

 

ANGLE plc (AIM: AGL), the technology commercialisation company, is pleased to announce that its 31%-owned portfolio company Geomerics, which specialises in computer games middleware, has successfully completed the third and final milestone in its corporate partnership with one of the world's leading technology companies ("Corporate Partner"), resulting in a final milestone payment being received by Geomerics.   

 

Geomerics and the Corporate Partner continue to work closely together. The name of the Corporate Partner and some of the terms of the deal, which was first announced in July 2010, remain subject to strict confidentiality.

 

The deal included investment in Geomerics of up to £2.3 million, of which approximately £1.0 million was subject to the achievement of certain milestones.  The total investment of £2.3 million has now been received.

 

The corporate partnership has resulted in the development of new capabilities to make Geomerics products 'next generation technology ready'.

 

 

Andrew Newland, Chief Executive of ANGLE, commented: 

"We are pleased to see the completion of the third and final milestone and the widening recognition and adoption by the computer games market of Enlighten, the real-time lighting solution developed by Geomerics."

 

 

 

 

For further information:

ANGLE plc

01483 685830

Andrew Newland, Chief Executive

Ian Griffiths, Finance Director

 


Cenkos Securities

Stephen Keys, Adrian Hargrave (Nominated adviser)

Andy Roberts (Sales)

 

020 7397 8900

Buchanan

Mark Court, Sophie Cowles 

 

020 7466 5000

Scott Harris

Stephen Scott, Harry Dee

0207 653 0030

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBCGDUUGBBGDU


Related Shares: Angle (AGL).




DateSourceHeadlineCategory
13-May-13 07:00RNSPARSORTIX CELL HARVESTINGCompany Announcement - General
07-May-13 07:00RNSParsortix Regulatory Approval UpdateCompany Announcement - General
28-Feb-13 07:00RNSParsortix Research Product LaunchCompany Announcement - General
15-Feb-13 10:56RNSDirector's share transferDirectors' Dealings
31-Jan-13 07:01RNSFundraising and Director's DealingsCompany Announcement - General
31-Jan-13 07:00RNSInterim ResultsResults and Trading Reports
16-Jan-13 07:00RNSNotification of Interim Results and WebcastCompany Announcement - General
15-Jan-13 07:00RNSAcolyte Biomedica SettlementCompany Announcement - General
14-Jan-13 07:00RNSParsortix Cell RecoveryCompany Announcement - General
07-Jan-13 07:00RNSAppointment of NEDExecutive Changes
18-Dec-12 07:00RNSParsortix Released to Research PartnersCompany Announcement - General
10-Dec-12 07:00RNSBUSINESS UPDATECompany Announcement - General
18-Oct-12 07:00RNSAppointment of Scientific AdvisersCompany Announcement - General
17-Oct-12 15:45RNSHolding(s) in the CompanyHolding(s) in Company
11-Oct-12 15:39RNSResult of 2012 Annual General MeetingResults and Trading Reports
03-Sep-12 07:00RNSIncreased FundraisingCompany Announcement - General
01-Aug-12 07:00RNSIncreased FundraisingCompany Announcement - General
26-Jul-12 07:01RNSFundraisingCompany Announcement - General
26-Jul-12 07:00RNSPreliminary ResultsResults and Trading Reports
24-Jul-12 07:00RNSNotice of Preliminary Results and Conference CallCompany Announcement - General
27-Jun-12 07:00RNSOffer Unconditional for Novocellus' Partner OrigioCompany Announcement - General
07-Jun-12 07:00RNSUpdate Re Novocellus' Partner ORIGIO A/SCompany Announcement - General
16-May-12 07:00RNSGeomerics Milestone PaymentCompany Announcement - General
30-Apr-12 07:00RNSParsortix Design BreakthroughCompany Announcement - General
26-Apr-12 07:00RNSLaunches New Corporate WebsiteCompany Announcement - General
23-Apr-12 07:00RNSParsortix Update for Breast CancerCompany Announcement - General
17-Apr-12 07:00RNSParsortix Validation for Ovarian CancerCompany Announcement - General
11-Apr-12 07:00RNSNovocellus Embryosure® Trial StartedCompany Announcement - General
15-Mar-12 07:00RNSParsortix Validation for Colon CancerCompany Announcement - General
07-Mar-12 08:00RNSHolding(s) in the CompanyHolding(s) in Company


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.